细胞增殖试剂盒市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按方法(比色法、荧光法和其他)、分析类型、最终用户和地理进行细分。

市场快照

Cell Proliferation Kit Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %
Cell Proliferation Kit Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

细胞增殖试剂盒 (CPK) 市场预计在预测期内的复合年增长率为 7.5%。促成市场增长的主要因素是全球被诊断患有癌症、肿瘤和正在进行的研发活动的患者数量不断增加。根据世界卫生组织的报告,癌症是全球死亡的主要原因,估计 2018 年有近 960 万人死亡。此外,肺癌被确定为导致死亡的最常见癌症,2018 年有 176 万人死亡。因此,患病率不断上升这些疾病导致早期评估活细胞计数,有效治疗的代谢活动推动了市场增长。此外,政府为控制医疗保健负担而采取的举措的增加以及人们对医疗保健意识的提高可能会推动细胞增殖试剂盒市场的发展。

报告范围

细胞增殖是细胞复制的过程,它通过用新细胞回收旧细胞,从胚胎发生到维持成体组织稳态发挥关键作用。在一些疾病如癌症中,会观察到异常的细胞增殖。因此,细胞增殖测定试剂盒在体外和体内条件下的各种疾病适应症的临床诊断中获得了牵引力。这些用于细胞活化的调查研究,评估细胞毒性和临床,以确定治疗效果。根据报告范围,对各类细胞增殖试剂盒进行了详细讨论。

Assay Type
DNA Synthesis Cell Proliferation Assay
Metabolic Activity Cell Proliferation Assay
Antigen Associated Cell Proliferation Assay
Method
Colorimetry
Fluorescence
Others
End-user
Pharma & Biotech Companies
Academic & Research Institutes
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

比色法细分市场有望在细胞增殖试剂盒市场占据主要市场份额

在预测期内,比色法在细胞增殖试剂盒市场占有重要的市场份额。主导地位是由于越来越多地采用作为细胞活动的测量标志物。对该方法的巨大需求是由于它们的成本效益、更容易检索高通量数据以及在评估治疗效果中的关键作用。该方法广泛用于测定各种细胞活性,如 DNA 合成、代谢活性、ATP 产生、存在的细胞数量等,可提供各种类型的比色测定法,如 WST-1、WST-8、XTT、MTT 等具体到测试。因此,上述因素预计将推动该细分市场的增长。

Cell Proliferation Kit Market Key Trends

北美预计将在市场上占有重要份额,预计在预测期内也将如此

预计北美将在细胞增殖试剂盒市场占据主要市场份额。占主导地位的原因是该地区每年都有越来越多的新癌症病例,如黑色素瘤、尿路上皮癌、肺癌等。此外,大量婴儿潮一代的存在导致大量老年人面临癌症风险。根据美国癌症协会公布的 2020 年估计,肺癌是第二大常见癌症,导致男性和女性死亡 135,720 人。此外,根据甲状腺癌幸存者协会的数据,2020 年美国有近 52,890 例新发甲状腺癌病例,比 2019 年的 52,070 例有所增加。因此,不断增长的癌症病例导致对确定推动市场增长的细胞群增长率的需求增加。此外,主要制药和生物技术公司正在进行的肿瘤学研究活动需要使用这些试剂盒来确定药物的治疗效率。因此,由于上述因素,预计在预测期内将在很大程度上推动该地区的细胞增殖试剂盒市场。

Cell Proliferation Kit Market Growth Rate

竞争格局

细胞增殖试剂盒市场竞争适度,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。目前主导市场的一些公司是默克公司、赛默飞世尔科技公司、Bio-Rad Laboratories Inc、Becton、Dickinson and Company 和安捷伦科技公司(BioTek Instruments Inc)。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Technological Advancements in Cell-based Methodologies

      2. 4.2.2 Rising Prevalence of Chronic Diseases and Lifestyle Disorders

      3. 4.2.3 Increasing Application in Drug Screening

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Skilled Personnel to Operate these Technologies

      2. 4.3.2 High Maintenance and Operational Costs

      3. 4.3.3 Lesser Sensitive Results with Smaller Samples of Cells

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Assay Type

      1. 5.1.1 DNA Synthesis Cell Proliferation Assay

      2. 5.1.2 Metabolic Activity Cell Proliferation Assay

      3. 5.1.3 Antigen Associated Cell Proliferation Assay

    2. 5.2 Method

      1. 5.2.1 Colorimetry

      2. 5.2.2 Fluorescence

      3. 5.2.3 Others

    3. 5.3 End-user

      1. 5.3.1 Pharma & Biotech Companies

      2. 5.3.2 Academic & Research Institutes

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific Inc

      2. 6.1.2 Merck KGaA

      3. 6.1.3 Bio-Rad Laboratories Inc

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Agilent Technologies Inc (BioTek Instruments Inc)

      6. 6.1.6 GE Healthcare

      7. 6.1.7 Perkin Elmer Inc

      8. 6.1.8 Biological Industry

      9. 6.1.9 Biotium

      10. 6.1.10 Mindray Medical International Limited

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The undefined market is studied from 2018 - 2026.

The undefined is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Merck KGaA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Becton, Dickinson and Company, Agilent Technologies Inc (BioTek Instruments Inc) are the major companies operating in undefined.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!